“In the United States, according to data from the American Society of Plastic Surgeons, around 500,000 Botox procedures were performed for hyperhidrosis annually, with a growing proportion of men seeking treatment. While men make up a smaller percentage of overall cosmetic Botox users, the use of Botox for medical reasons, such as hyperhidrosis, is becoming more common among men.
It's estimated that men account for 10-20% of Botox users for conditions like hyperhidrosis, meaning tens of thousands of men may be using Botox to manage excessive sweating in various countries.”
-———————————————————————————
Around 30-50% of hyperhidrosis cases are considered more severe, often classified as primary focal hyperhidrosis. This form of hyperhidrosis tends to be localized (affecting areas like the hands, feet, underarms, or face) and can significantly impact daily life, social interactions, and emotional well-being. More severe cases often involve uncontrollable sweating that occurs even without triggers like heat or exercise, and can interfere with work, personal activities, and mental health. Many people with severe hyperhidrosis seek medical treatments, such as Botox injections, prescription antiperspirants, or even surgical interventions, to manage the condition.
———————————————————————————-
There looks to be a large enough market for multiple treatments, and the strong % with primary focal hyperhidrosis cases points to an equally strong potential for Sofdra becoming a primary treatment - to fix a deeply personal and hard to conceal condition. Just this past weekend at a wedding, a family member complained about being unusually sweat-ridden and outwardly embarrassed. It wasn’t hot enough to justify. But they don’t like Botox particularly - as a middle-aged man. Younger aspirants may feel altogether differently. So what treatment will they choose? The popular option with a marginal stigma attached, or a specifically targeted non-invasive option?
In this persistently cautious economic environment, I’d back in price as the primary consideration, so interested to know the different costs of all available treatment options. At-home treatments are far far easier than visiting a beauty shop for injections. Although every 6 months…it would be a tough call.
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-10516
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.5M |
Open | High | Low | Value | Volume |
32.5¢ | 32.5¢ | 31.5¢ | $1.940M | 6.061M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 470483 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 33000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 453608 | 0.315 |
27 | 806928 | 0.310 |
11 | 241226 | 0.305 |
30 | 490096 | 0.300 |
6 | 120637 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 33000 | 1 |
0.325 | 105900 | 2 |
0.330 | 80538 | 3 |
0.335 | 285000 | 3 |
0.340 | 646646 | 5 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online